Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review(±)-1-(1,2-Diphenylethyl)piperidine maleate
Description: NMDA antagonist; acts at ion channel site
Biological Activity
High affinity antagonist at the ion channel on the NMDA receptor.
Technical Data
| M. Wt | 381.47 |
| Formula | C19H23N.C4H4O4 |
| Storage | Store at RT |
| CAS Number | 207461-99-2 |
| PubChem ID | 16657069 |
| InChI Key | AEHZEDLXDLPQQD-BTJKTKAUSA-N |
| Smiles | OC(=O)\C=C/C(O)=O.C(C(N1CCCCC1)C1=CC=CC=C1)C1=CC=CC=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets
References
References are publications that support the biological activity of the product.
Ragawski (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. TiPS 14 325 PMID: 7504360
View Related Products by Target
View Related Products by Product Action
Keywords: (±)-1-(1,2-Diphenylethyl)piperidine maleate, (±)-1-(1,2-Diphenylethyl)piperidine maleate supplier, NMDA, antagonists, ion, channel, site, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, 0360, Tocris Bioscience
1 Citation for (±)-1-(1,2-Diphenylethyl)piperidine maleate
Citations are publications that use Tocris products. Selected citations for (±)-1-(1,2-Diphenylethyl)piperidine maleate include:
Ataka et al (2012) Alteration of antral and proximal colonic motility induced by chronic psychological stress involves central urocortin 3 and vasopressin in rats. Am J Physiol Gastrointest Liver Physiol 303 G519 PMID: 22651925
Reviews for (±)-1-(1,2-Diphenylethyl)piperidine maleate
There are currently no reviews for this product. Be the first to review (±)-1-(1,2-Diphenylethyl)piperidine maleate and earn rewards!
Have you used (±)-1-(1,2-Diphenylethyl)piperidine maleate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Huntington's Disease Research Product Guide
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
- Somatic Instability
- Proteolysis and Inclusion Bodies
- Transcriptional Dysregulation
- Mitochondrial Dysfunction
- Nuclear-Cytoplasmic Transport Interference
- Excitotoxicity
- Stem Cells
Alzheimer's Disease Poster
Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's Disease Poster
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.